AFM-Telethon is funding a 2-year project focusing on the excitatory and inhibitory brain alterations encountered in myotonic dystrophy type 1 (DM1). The consortium, which is made up of four partners from the Institut de Myologie, ENS, ICM and CRNL, is coordinated by NeuroDialyTics and SLEEP.